Why the study?
Dexmedetomidine may induce antiarrhythmic effects, especially against ventricular tachycardia, but the underlying electrophysiological mechanisms remain to be fully elucidated.
Does dexmedetomidine alter electrophysiological properties in human-induced pluripotent stem cell-derived cardiomyocytes?
Population
Ventricular-like human-induced pluripotent stem cell-derived cardiomyocytes
Comparison
Dexmedetomidine exposure
Design
Patch-clamp electrophysiological study
Authors
Loading...
DMED effects in hiPSC-CMs require in vivo validation; leaves open clinical antiarrhythmic translation.
Does dexmedetomidine alter electrophysiological properties in human-induced pluripotent stem cell-derived cardiomyocytes?
Dexmedetomidine exhibits antiarrhythmic effects on hiPSC-CMs by inhibiting sodium and calcium channels independently of adrenergic and imidazoline receptors.
Li et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: